Ebbing, E. A., Medema, J. P., Damhofer, H., Meijer, S. L., Krishnadath, K. K., van Berge Henegouwen, M. I., . . . van Laarhoven, H. W. M. (2016). ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Oncotarget.
Citação norma ChicagoEbbing, Eva A., Jan Paul Medema, Helene Damhofer, Sybren L. Meijer, Kausilia K. Krishnadath, Mark I. van Berge Henegouwen, Maarten F. Bijlsma, and Hanneke W. M. van Laarhoven. "ADAM10-mediated Release of Heregulin Confers Resistance to Trastuzumab By Activating HER3." Oncotarget 2016.
MLA citiranjeEbbing, Eva A., et al. "ADAM10-mediated Release of Heregulin Confers Resistance to Trastuzumab By Activating HER3." Oncotarget 2016.
Opozorilo: Ti citati niso vedno 100% točni.